TOP REASONS TO CONDUCT YOUR CLINICAL TRIALS IN LATVIA

  Latvia is a country in the Baltic region of Northern Europe, is in EU since 2004, follows EU requirements, ICH-GCP and Helsinki declaration for clinical trials.

  Clinical trial in Latvia is a quick clinical trial start-up process. 

  Fast approval process, average about 2 months.

  Most hospitals are well-equipped.

  The Latvia has a significant incidence of oncological and cardiovascular diseases

  The region has one of the highest cardiovascular mortality rates in the European Union. Furthermore, similar to most of the Central and Eastern European countries the Baltics States can offer a considerably large pool of treatment-native subjects.

  In Latvia it is allowed to conduct Phase 1 for volunteers.

  Starting from year 2023 there are changes in the clinical trials submission procceses in EU via  single link Clinical Trials Information System (CTIS).